Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 186 citing articles:

Psychedelics
David E. Nichols
Pharmacological Reviews (2016) Vol. 68, Iss. 2, pp. 264-355
Open Access | Times Cited: 1304
Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways
Juan F. López‐Giménez, Javier González‐Maeso
Current topics in behavioral neurosciences (2017), pp. 45-73
Open Access | Times Cited: 225
Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species
Adam L. Halberstadt, Muhammad Chatha, Adam K. Klein, et al.
Neuropharmacology (2020) Vol. 167, pp. 107933-107933
Open Access | Times Cited: 187
The neural basis of psychedelic action
Alex C. Kwan, David E. Olson, Katrin H. Preller, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 11, pp. 1407-1419
Closed Access | Times Cited: 167
Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice
Mario de la Fuente Revenga, Bohan Zhu, Christopher A. Guevara, et al.
Cell Reports (2021) Vol. 37, Iss. 3, pp. 109836-109836
Open Access | Times Cited: 151
The promises and perils of psychedelic pharmacology for psychiatry
Tristan McClure‐Begley, Bryan L. Roth
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 6, pp. 463-473
Closed Access | Times Cited: 139
A non-hallucinogenic LSD analog with therapeutic potential for mood disorders
Vern Lewis, Emma M. Bonniwell, Janelle K. Lanham, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112203-112203
Open Access | Times Cited: 68
Characterization of the head-twitch response induced by hallucinogens in mice
Adam L. Halberstadt, Mark A. Geyer
Psychopharmacology (2013) Vol. 227, Iss. 4, pp. 727-739
Open Access | Times Cited: 173
Serotonin 5-HT2A Receptor Activation Blocks TNF-α Mediated Inflammation In Vivo
Felix Nau, Bangning Yu, David Martin, et al.
PLoS ONE (2013) Vol. 8, Iss. 10, pp. e75426-e75426
Open Access | Times Cited: 160
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Esa R. Korpi, Bjørnar den Hollander, Usman Farooq, et al.
Pharmacological Reviews (2015) Vol. 67, Iss. 4, pp. 872-1004
Open Access | Times Cited: 133
Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities
Attila Szabó
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 124
d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology
Danilo De Gregorio, Stefano Comai, Luca Posa, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 11, pp. 1953-1953
Open Access | Times Cited: 105
Pharmacology and Toxicology of N-Benzylphenethylamine (“NBOMe”) Hallucinogens
Adam L. Halberstadt
Current topics in behavioral neurosciences (2017), pp. 283-311
Open Access | Times Cited: 91
Investigation of the Structure–Activity Relationships of Psilocybin Analogues
Adam K. Klein, Muhammad Chatha, Lauren J. Laskowski, et al.
ACS Pharmacology & Translational Science (2020) Vol. 4, Iss. 2, pp. 533-542
Open Access | Times Cited: 78
Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison
Pantelis Leptourgos, Martin Fortier-Davy, Robin Carhart‐Harris, et al.
Schizophrenia Bulletin (2020) Vol. 46, Iss. 6, pp. 1396-1408
Open Access | Times Cited: 75
Advantages and Limitations of Animal Schizophrenia Models
Magdalena Białoń, Agnieszka Wąsik
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 5968-5968
Open Access | Times Cited: 67
Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice
Grant C. Glatfelter, Eline Pottie, John S. Partilla, et al.
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 11, pp. 1181-1196
Open Access | Times Cited: 56
“Selective” serotonin 5-HT2A receptor antagonists
Austen B. Casey, Meng Cui, Raymond G. Booth, et al.
Biochemical Pharmacology (2022) Vol. 200, pp. 115028-115028
Open Access | Times Cited: 53
Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response
I. Erkizia-Santamaría, R. Alles-Pascual, Igor Horrillo, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113612-113612
Open Access | Times Cited: 51
Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation
Gilly Wolf, Sandeep Singh, Karin Blakolmer, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 44-58
Closed Access | Times Cited: 38
UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice
Daniel Ryskamp Rijsketic, Austen B. Casey, Daniel A. N. Barbosa, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 12, pp. 1798-1807
Open Access | Times Cited: 28
Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics
Alaina M. Jaster, Javier González‐Maeso
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3595-3612
Open Access | Times Cited: 22
1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents – A Review
Richard A. Glennon, Małgorzata Dukat
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 6, pp. 1722-1745
Open Access | Times Cited: 10
Psychedelic-like Activity of Norpsilocin Analogues
Alexander M. Sherwood, Elise K. Burkhartzmeyer, Samuel E. Williamson, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 2, pp. 315-327
Open Access | Times Cited: 9
Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response
Adam L. Halberstadt, Mark A. Geyer
Neuropharmacology (2013) Vol. 77, pp. 200-207
Open Access | Times Cited: 100
Page 1 - Next Page

Scroll to top